ASX:PME Pro Medicus (PME) Stock Price, News & Analysis → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free PME Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume285,954 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield0.35%Price TargetN/A Stock AnalysisStock Analysis Get Pro Medicus alerts: Email Address Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About Pro Medicus Stock (ASX:PME)Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.Read More Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him PME Stock News HeadlinesApril 19, 2024 | msn.com1 ASX artificial intelligence (AI) stock that could help turbocharge your portfolioApril 17, 2024 | msn.comGoldman Sachs just slapped a buy rating on this ASX 200 tech stockApril 23, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.April 11, 2024 | finance.yahoo.comPro Medicus' (ASX:PME) 45% CAGR outpaced the company's earnings growth over the same five-year periodApril 11, 2024 | msn.comThe pros and cons of buying this ASX tech ETF after its 30% rallyMarch 12, 2024 | fool.com.au2 ASX 200 shares to buy in the most 'interesting' sector right nowFebruary 29, 2024 | msn.comClosing Bell: Buyers ambush benchmark setting new benchmarkFebruary 25, 2024 | afr.comPro Medicus share price pause ‘a good entry point’April 23, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.February 19, 2024 | finance.yahoo.comPro Medicus Limited (PME.XA)February 15, 2024 | msn.comWhy relentless innovation is Pro Medicus’ biggest opportunity and riskFebruary 15, 2024 | msn.comAustralia stocks higher at close of trade; S&P/ASX 200 up 0.77%February 14, 2024 | fool.com.auThis ASX 200 healthcare stock is sinking 6% despite explosive first-half earnings growthFebruary 14, 2024 | investing.comPro Medicus Ltd (PME)February 12, 2024 | finance.yahoo.comDespite recent sales, Pro Medicus Limited (ASX:PME) insiders still hold the largest share with a 51% interestFebruary 5, 2024 | msn.comPro Medicus (PME) Shares Rally on Launch of Imaging Tech for AppleFebruary 4, 2024 | msn.comASX Health Stocks: Radiopharm’s results published; ProMedicus launches on Apple Vision ProFebruary 4, 2024 | fool.com.auApple Vision Pro and an ASX 200 healthcare share hitting all-time highsFebruary 2, 2024 | msn.comTaking the profit on Pro Medicus? Nice one. You just broke the 1st Rule of Compounding GrowthJanuary 14, 2024 | finance.yahoo.comHere's Why We Think Pro Medicus (ASX:PME) Might Deserve Your Attention TodayDecember 11, 2023 | fool.com.auCould Core Lithium be a millionaire-maker stock?November 27, 2023 | msn.comWhy microcaps could be the biggest opportunity in markets todayNovember 21, 2023 | fool.com.auGuess which ASX 200 stock's founders just sold $176m of sharesNovember 19, 2023 | fool.com.auWhy have Pro Medicus shares hit a record high on Monday?November 12, 2023 | fool.com.auPro Medicus share price eclipses 52-week high on fresh $20 million contractNovember 9, 2023 | finance.yahoo.comVisage Soars with CloudPACS at RSNA 2023November 3, 2023 | finance.yahoo.comPro Medicus (ASX:PME) jumps 7.4% this week, though earnings growth is still tracking behind five-year shareholder returnsSee More Headlines Receive PME Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pro Medicus and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 3/21 Dividend2/28/2024Dividend Payable3/21/2024Today4/22/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolASX:PME CUSIPN/A CIKN/A Webwww.promed.com.au Phone61 3 9429 8800FaxN/AEmployees2,060Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.66 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth3.87Net Income$69.71 million Net Margins49.05% Pretax MarginN/A Return on Equity50.49% Return on Assets30.78% Debt Debt-to-Equity Ratio0.97 Current Ratio7.49 Quick Ratio4.39 Sales & Book Value Annual Sales$142.12 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow71.76 Book ValueA$1.52 per share Price / BookN/AMiscellaneous Outstanding Shares104,420,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.52 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesDr. Sam Aaron Hupert M.B.B.S.M.D., Co-Founder, CEO, MD & Executive DirectorMr. Anthony Barry Hall B.Sc.B.Sc.(Hons), M.Sc., Co-Founder, Technology Director & Executive DirectorMr. Clayton James Hatch B.CommCPA, CPA, Chief Financial OfficerDr. Malte WesterhoffGM of Europe & Global CTOMr. Brad LevinGM of North America & Global Head of MarketingMs. Sharni L. RedenbachPeople & Culture DirectorMr. Sean LambrightGlobal Head of Sales - Visage Imaging IncMs. Teresa GschwindGlobal Head of Customer Service of Visage Imaging Inc.Ms. Danny English C.A.Financial Controller & Company SecretaryMore ExecutivesKey Competitors1st GroupASX:1STAclarionNASDAQ:ACONWAlcidion GroupASX:ALCAlternate HealthOTCMKTS:AHGIFArcturis DataOTCMKTS:SSYNFView All CompetitorsInsidersAlice WilliamsBought 850 shares on 2/21/2024Total: $74,681.00 ($87.86/share)Alice WilliamsBought 810 shares on 2/16/2024Total: $72,874.89 ($89.97/share)Alice WilliamsBought 250 shares on 11/27/2023Total: $22,510.00 ($90.04/share)Anthony HallSold 1,000,000 sharesTotal: $88.02 M ($88.02/share)Anthony HallSold 70,000 sharesTotal: $5.03 M ($71.86/share) PME Stock Analysis - Frequently Asked Questions How often does Pro Medicus pay dividends? What is the dividend yield for Pro Medicus? Pro Medicus declared a Interim dividend on Thursday, February 22nd. Shareholders of record on Thursday, March 21st will be given a dividend of 0.18 per share on Thursday, March 21st. This represents a yield of 0.19%. The ex-dividend date of this dividend is Wednesday, February 28th. This is a positive change from the stock's previous Interim dividend of A$0.13. Read our dividend analysis for PME. Is Pro Medicus a good dividend stock? Pro Medicus (ASX:PME) pays an annual dividend of A$0.36 per share and currently has a dividend yield of 0.35%. The dividend payout ratio is 54.55%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for PME. What other stocks do shareholders of Pro Medicus own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pro Medicus investors own include ImmuPharma (IMM), Blackmores (BKL), Bank of America (BAC), Boeing (BA), Accent Group (AX1), Axos Financial (AX), ARB (ARB), Appen (APX), Arista Networks (ANET) and Altium (ALU). This page (ASX:PME) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro Medicus Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
